EP2490530A4 - Composés et méthodes pour le traitement d'infections bactériennes - Google Patents

Composés et méthodes pour le traitement d'infections bactériennes

Info

Publication number
EP2490530A4
EP2490530A4 EP10825785.8A EP10825785A EP2490530A4 EP 2490530 A4 EP2490530 A4 EP 2490530A4 EP 10825785 A EP10825785 A EP 10825785A EP 2490530 A4 EP2490530 A4 EP 2490530A4
Authority
EP
European Patent Office
Prior art keywords
compounds
methods
bacterial infections
treating bacterial
treating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP10825785.8A
Other languages
German (de)
English (en)
Other versions
EP2490530A1 (fr
Inventor
James W Janetka
Zhenfu Han
Scott Hultgren
Jerry Pinkner
Corinne Cusumano
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Washington
Washington University in St Louis WUSTL
Original Assignee
University of Washington
Washington University in St Louis WUSTL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Washington, Washington University in St Louis WUSTL filed Critical University of Washington
Priority to EP18214928.6A priority Critical patent/EP3492483A1/fr
Publication of EP2490530A1 publication Critical patent/EP2490530A1/fr
Publication of EP2490530A4 publication Critical patent/EP2490530A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/18—Acyclic radicals, substituted by carbocyclic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • C07H15/203—Monocyclic carbocyclic rings other than cyclohexane rings; Bicyclic carbocyclic ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/26—Acyclic or carbocyclic radicals, substituted by hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/06—Benzopyran radicals
    • C07H17/065—Benzo[b]pyrans
    • C07H17/075—Benzo[b]pyran-2-ones
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
EP10825785.8A 2009-10-22 2010-10-22 Composés et méthodes pour le traitement d'infections bactériennes Withdrawn EP2490530A4 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP18214928.6A EP3492483A1 (fr) 2009-10-22 2010-10-22 Composés et méthodes pour le traitement d'infections bactériennes

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US25413509P 2009-10-22 2009-10-22
US32173810P 2010-04-07 2010-04-07
US38453510P 2010-09-20 2010-09-20
PCT/US2010/053848 WO2011050323A1 (fr) 2009-10-22 2010-10-22 Composés et méthodes pour le traitement d'infections bactériennes

Related Child Applications (1)

Application Number Title Priority Date Filing Date
EP18214928.6A Division EP3492483A1 (fr) 2009-10-22 2010-10-22 Composés et méthodes pour le traitement d'infections bactériennes

Publications (2)

Publication Number Publication Date
EP2490530A1 EP2490530A1 (fr) 2012-08-29
EP2490530A4 true EP2490530A4 (fr) 2014-01-22

Family

ID=43900714

Family Applications (2)

Application Number Title Priority Date Filing Date
EP10825785.8A Withdrawn EP2490530A4 (fr) 2009-10-22 2010-10-22 Composés et méthodes pour le traitement d'infections bactériennes
EP18214928.6A Withdrawn EP3492483A1 (fr) 2009-10-22 2010-10-22 Composés et méthodes pour le traitement d'infections bactériennes

Family Applications After (1)

Application Number Title Priority Date Filing Date
EP18214928.6A Withdrawn EP3492483A1 (fr) 2009-10-22 2010-10-22 Composés et méthodes pour le traitement d'infections bactériennes

Country Status (2)

Country Link
EP (2) EP2490530A4 (fr)
WO (1) WO2011050323A1 (fr)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2009279787B2 (en) 2008-08-04 2014-05-29 Chdi Foundation, Inc. Certain kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof
EP2513128A2 (fr) * 2009-12-14 2012-10-24 University of Basel Dérivés de mannose en tant qu'antagonistes de l'adhésion bactérienne
MX2012008346A (es) 2010-01-25 2012-11-12 Chdi Foundation Inc Determinados inhibidores de cinurenina-3-monooxigenasa, composiciones farmceuticas y metodos de uso de los mismos.
ES2732311T3 (es) 2011-02-07 2019-11-21 Univ Washington Compuestos de manósidos y procedimientos de uso de los mismos
WO2012164074A1 (fr) * 2011-06-03 2012-12-06 University Of Basel Dérivés de mannose phosphate en tant qu'antagonistes de l'adhésion bactérienne
SG2014012926A (en) 2011-08-30 2014-06-27 Chdi Foundation Inc Kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof
AU2012300246A1 (en) 2011-08-30 2014-03-06 Chdi Foundation, Inc. Kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof
SG11201504813XA (en) * 2012-12-18 2015-07-30 Vertex Pharma Mannose derivatives for treating bacterial infections
AU2014248717B2 (en) 2013-03-12 2018-03-29 Vertex Pharmaceuticals Incorporated Mannose derivatives for treating bacterial infections
EP3003322B1 (fr) 2013-05-30 2023-09-13 Washington University Dérivés du mannose et leur utilisation dans le traitement d'infections bactériennes
US10258621B2 (en) 2014-07-17 2019-04-16 Chdi Foundation, Inc. Methods and compositions for treating HIV-related disorders
CN104119407B (zh) * 2014-07-31 2017-07-28 济南尚博生物科技有限公司 一种甲基‑2,3,4‑三氧‑苄基‑β‑D‑吡喃核糖苷的合成方法
CN105622685B (zh) * 2015-12-31 2019-08-23 杭州科本药业有限公司 一种糖基苯并咪唑化合物及其制备方法和应用
AU2017238392A1 (en) 2016-03-23 2018-09-27 Fimbrion Therapeutics, Inc. Mannose-derived antagonists of FimH useful for treating disease
US11898210B2 (en) 2017-10-16 2024-02-13 Enterome Tools for assessing FimH blockers therapeutic efficiency
SI3762368T1 (sl) 2018-03-08 2022-06-30 Incyte Corporation Aminopirazin diolne spojine kot zaviralci PI3K-y
US11046658B2 (en) 2018-07-02 2021-06-29 Incyte Corporation Aminopyrazine derivatives as PI3K-γ inhibitors
LT3820856T (lt) 2018-07-10 2022-11-10 Glaxosmithkline Intellectual Property Development Limited C-manozido junginiai, naudingi šlapimo takų infekcijoms gydyti
AR117472A1 (es) 2018-12-21 2021-08-11 Celgene Corp Inhibidores de tienopiridina de ripk2
EP3966210A1 (fr) * 2019-05-07 2022-03-16 GlaxoSmithKline Intellectual Property Development Limited Nouveaux composés
CN111423478A (zh) * 2020-04-16 2020-07-17 山东大学 一种含有炔丙基的木糖及其合成方法
CN117986219A (zh) * 2022-08-22 2024-05-07 三峡大学 一种6-芳/烷硫基-2h-吡喃-3-酮类化合物制备硫糖苷的方法

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0383092A2 (fr) * 1989-02-13 1990-08-22 Bayer Corporation Substrats enzymatiques chromogéniques à base de mérocyanine
US20070167378A1 (en) * 2003-10-08 2007-07-19 Saraiva Maria Joao M Compounds useful for the treatment of diseases associated with the formation of amyloid fibrils

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6420127B1 (en) * 1994-11-18 2002-07-16 Washington University Compounds and pharmaceutical compositions for the treatment and prophylaxis of bacterial infections
US20080171706A1 (en) * 2004-03-23 2008-07-17 Vlaams Interuniversitair Instituut Voor Biotechnologie Vzw Anti-Adhesive Compounds to Prevent and Treat Bacterial Infections

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0383092A2 (fr) * 1989-02-13 1990-08-22 Bayer Corporation Substrats enzymatiques chromogéniques à base de mérocyanine
US20070167378A1 (en) * 2003-10-08 2007-07-19 Saraiva Maria Joao M Compounds useful for the treatment of diseases associated with the formation of amyloid fibrils

Non-Patent Citations (8)

* Cited by examiner, † Cited by third party
Title
A. STOLL ET AL: "Das Furocumarin und die beta-D-Glucosido-furocumarinsäure aus den Samen von Coronilla-Arten. 23. Mitteilung über Herzglykoside", HELVETICA CHIMICA ACTA, vol. 33, no. 6, 1 January 1950 (1950-01-01), pages 1637 - 1647, XP055094084, ISSN: 0018-019X, DOI: 10.1002/hlca.19500330631 *
DENNIS A. SHUMAN ET AL: "Synthesis and biological activity of certain 8-mercaptopurine and 6-mercaptopyrimidine S-nucleosides", JOURNAL OF MEDICINAL CHEMISTRY, vol. 12, no. 4, 1 July 1969 (1969-07-01), pages 653 - 657, XP055094096, ISSN: 0022-2623, DOI: 10.1021/jm00304a021 *
FAROUK M E ABDEL-MEGEID ET AL: "PREPARATION AND SOME REACTIONS OF D-GLUCOSYL DERIVATIVES OF 2-THIOXO-1,3,4-OXADIAZOLES AND 2-THIOXO- 1,3,4-THIADIAZOLES AND THEIR 2-OXO ANALOGUES*", CARBOHYDRATE RESEARCH, vol. 59, 1 January 1977 (1977-01-01), pages 95 - 102, XP055094075 *
NORIKO NAGAHORI ET AL: "Inhibition of Adhesion of Type 1 Fimbriated Escherichia coli to Highly Mannosylated Ligands Shin-Ichiro Nishimura, [b]", CHEMBIOCHEM, vol. 50, no. 3, 1 January 2002 (2002-01-01), pages 836 - 844, XP055094204 *
R BOGNAR: "N-GLYKOSYL-DERIVATE 'l-F.IL XIII. DER NACHTRÄGLICHE AUSBAU DES AGLYKONS. SYNTHESE VON N-GLYKOSYL- DERIVATEN DES 2-AMINO-THIAZOLS, 2-AMINO-1,3,4-THIADIAZOLS UND 5-AMINO-1,2,3,4-THIATRIAZOLS", CARBOHYDRATE RESEARCH, vol. 5, 1 January 1967 (1967-01-01), pages 320 - 328, XP055094071 *
See also references of WO2011050323A1 *
V. S. TAILE ET AL: "Synthesis and biological evaluation of novel 2-(4-O-[beta]-D-glucosidoxyphenyl)-4,5-disubstituted imidazoles", JOURNAL OF HETEROCYCLIC CHEMISTRY, vol. 47, no. 4, 17 July 2010 (2010-07-17), pages 903 - 907, XP055094097, ISSN: 0022-152X, DOI: 10.1002/jhet.433 *
W. T. HASKINS: "Reliations between Rotatory Power and Structure in the Sugar Group. XXXV. Some 2'-Naohthyl 1-Thioglycopyranosides and their Acetates", JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, vol. 69, no. 7, 19 July 1947 (1947-07-19), pages 1668 - 1672, XP055094092, ISSN: 0002-7863, DOI: 10.1021/ja01199a030 *

Also Published As

Publication number Publication date
EP2490530A1 (fr) 2012-08-29
EP3492483A1 (fr) 2019-06-05
WO2011050323A1 (fr) 2011-04-28

Similar Documents

Publication Publication Date Title
HK1247841A1 (zh) 苯並氧雜硼雜環戊二烯衍生物用於治療細菌感染
EP2490530A4 (fr) Composés et méthodes pour le traitement d'infections bactériennes
AP3269A (en) Methods and compounds for treating paramyxoviridaevirus infections
EP2408753A4 (fr) Composés et procédés pour traiter les infections microbiennes gastro-intestinales mammaliennes
ZA201005798B (en) Treatment of microbial infections
IL217492A0 (en) Treatment method
DK2473482T3 (en) Methods of treating orthomyxoviral infections
PL2424559T3 (pl) Sposoby leczenia zakażeń bakteryjnych z zastosowaniem orytawancyny
EP2400843A4 (fr) Iminosucres et procédés de traitement d'infections arénavirales
EP2564835A4 (fr) Forme pharmaceutique solide à dissolution rapide pour le traitement d'infections bactériennes
EP2536282A4 (fr) Procédés pour traiter l'infection
EP2493442A4 (fr) Dispositifs, méthodes et composition permettant de lutter contre les infections
EP2512504A4 (fr) Composition et méthode thérapeutique
ZA201202924B (en) Compositions and methods for treating bacterial infections using ceftaroline
EP2429290A4 (fr) Composés et méthodes utilisables dans le cadre du traitement du sida et des infections par le vih
ZA201308116B (en) Avian-based treatment for microbial infections
ZA201204249B (en) Treatment of microbial infections
EP2772248A4 (fr) Composition pharmaceutique et kit pour traiter les infections bactériennes
IL216957A0 (en) Exo-s-mecamylamine method, use, and compound for treatment
GB0801768D0 (en) Treatment of microbial infections
ZA201104003B (en) Drug for treating infections
EP2403496A4 (fr) Composés et procédés pour le traitement d'un cancer et d'infections virales
GB0914373D0 (en) Treatment method

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20120514

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

RIN1 Information on inventor provided before grant (corrected)

Inventor name: HULTGREN, SCOTT

Inventor name: CUSUMANO, CORINNE

Inventor name: HAN, ZHENFU

Inventor name: JANETKA, JAMES, W.

Inventor name: PINKNER, JERRY

DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20140107

RIC1 Information provided on ipc code assigned before grant

Ipc: C07H 15/18 20060101AFI20131219BHEP

Ipc: C07H 17/075 20060101ALI20131219BHEP

Ipc: C07H 15/203 20060101ALI20131219BHEP

Ipc: A61P 31/02 20060101ALI20131219BHEP

Ipc: C07H 17/04 20060101ALI20131219BHEP

Ipc: C07H 17/00 20060101ALI20131219BHEP

Ipc: A61K 31/70 20060101ALI20131219BHEP

Ipc: A61P 31/04 20060101ALI20131219BHEP

Ipc: C07H 15/26 20060101ALI20131219BHEP

17Q First examination report despatched

Effective date: 20160714

RIC1 Information provided on ipc code assigned before grant

Ipc: A61P 31/02 20060101ALI20180110BHEP

Ipc: A61P 31/04 20060101ALI20180110BHEP

Ipc: A61K 31/70 20060101ALI20180110BHEP

Ipc: C07H 17/00 20060101ALI20180110BHEP

Ipc: C07H 15/20 20060101AFI20180110BHEP

Ipc: C07H 15/26 20060101ALI20180110BHEP

Ipc: C07H 15/203 20060101ALI20180110BHEP

Ipc: C07H 17/075 20060101ALI20180110BHEP

Ipc: C07H 17/04 20060101ALI20180110BHEP

Ipc: C07H 15/18 20060101ALI20180110BHEP

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

INTG Intention to grant announced

Effective date: 20180226

GRAJ Information related to disapproval of communication of intention to grant by the applicant or resumption of examination proceedings by the epo deleted

Free format text: ORIGINAL CODE: EPIDOSDIGR1

INTC Intention to grant announced (deleted)
GRAJ Information related to disapproval of communication of intention to grant by the applicant or resumption of examination proceedings by the epo deleted

Free format text: ORIGINAL CODE: EPIDOSDIGR1

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

INTG Intention to grant announced

Effective date: 20180817

INTG Intention to grant announced

Effective date: 20180823

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20190103